Vita Life Sciences Limited
VLS
Rank in Stocks
#19698
Vita Life Sciences Limited is an Australian healthcare company specializing in... Vita Life Sciences Limited is an Australian healthcare company specializing in the formulation, packaging, distribution, and sale of vitamins and nutritional supplements. The company's reach spans Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. In addition to core supplements, their product range encompasses minerals, various herbs, and superfoods. They offer solutions targeting a broad spectrum of therapeutic areas, including nervous system support, general nutrition, immunity, hair, skin, and nails, liver and digestion, weight management, cardiovascular health, pain and inflammation, pregnancy and breastfeeding, and health specifically for men, women, and children. Products also provide antioxidant benefits and support for bones and joints. Marketed under their prominent brands—Herbs of Gold, VitaHealth, and VitaScience—these offerings are sold through pharmacies and health food channels. Established in 1947, Vita Life Sciences Limited is headquartered in Kirrawee, Australia.
Share Price
$1.85
Last synced: 2026-11-10
Market Cap
$99.62M
Change (1 day)
1.14%
Change (1 year)
18.01%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Vita Life Sciences Limited (VLS)
Category
Healthcare
EPS for Vita Life Sciences Limited (VLS)
EPS as of June 2026 TTM: $0.14
According to Vita Life Sciences Limited's latest financial reports, its current EPS (TTM) is $0.14. At the end of 2025 the company had an EPS of $0.13, an increase over its 2024 EPS of $0.10.
EPS history for Vita Life Sciences Limited from 2007 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.14 | 8.54% |
| 2025 | $0.13 | 27.34% |
| 2024 | $0.10 | -14.08% |
| 2023 | $0.12 | 30.85% |
| 2022 | $0.09 | -23.90% |
| 2021 | $0.12 | 25.87% |
| 2020 | $0.09 | 129.85% |
| 2019 | $0.04 | 28.43% |
| 2018 | $0.03 | -23.10% |
| 2017 | $0.04 | -6.86% |
| 2016 | $0.04 | -23.87% |
| 2015 | $0.06 | -45.95% |
| 2014 | $0.11 | 40.48% |
| 2013 | $0.08 | 67.26% |
| 2012 | $0.05 | 109.26% |
| 2011 | $0.02 | -74.22% |
| 2010 | $0.08 | -1,544.83% |
| 2009 | $-0.01 | -213.73% |
| 2008 | $0.01 | -160.71% |
| 2007 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 4,507.65% |
DE
|
|
| $6.08 | 4,207.30% |
DE
|
|
| $1.55 | 998.94% |
JP
|
|
| $3.66 | 2,493.91% |
CH
|
|
| $0.45 | 218.92% |
IL
|
Questions about Vita Life Sciences Limited's earnings per share (EPS)
What is Vita Life Sciences Limited's earnings per share (EPS)?
Vita Life Sciences Limited's earnings per share (EPS) over the last twelve months is $0.14, as of Jun 2026.
What was Vita Life Sciences Limited's earnings per share (EPS) in 2025?
In 2025, Vita Life Sciences Limited's earnings per share (EPS) was $0.13, 30.00% more than in 2024 ($0.10).
How has Vita Life Sciences Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Vita Life Sciences Limited's earnings per share (EPS) went from $0.09 to $0.13, an average growth of 7.63% a year.
How does Vita Life Sciences Limited's earnings per share (EPS) compare with similar companies?
Vita Life Sciences Limited's earnings per share (EPS) ($0.14) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.